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ERK1/2n−3 polyunsaturated fatty acids exert growth-inhibitory and pro-apoptotic effects in colon cancer cells. We
hypothesized that the anti-apoptotic glucose related protein of 78 kDa (GRP78), originally described as a
component of the unfolded protein response in endoplasmic reticulum (ER), could be a molecular target
for docosahexaenoic acid (DHA) in these cells. GRP78 total and surface overexpression was previously asso-
ciated with a poor prognosis in several cancers, whereas its down-regulation with decreased cancer growth
in animal models. DHA treatment induced apoptosis in three colon cancer cell lines (HT-29, HCT116 and
SW480), and inhibited their total and surface GRP78 expression. The cell ability to undergo DHA-induced apo-
ptosis was inversely related to their level of GRP78 expression. The transfection of the low GRP78-expressing
SW480 cells with GRP78-GFP cDNA signiﬁcantly induced cell growth and inhibited the DHA-driven apoptosis,
thus supporting the essential role of GRP78 in DHA pro-apoptotic effect.We suggest that pERK1/2 could be the
ﬁrst upstream target for DHA, and demonstrate that, downstream of GRP78, DHA may exert its proapoptotic
role by augmenting the expression of the ER resident factors ERdj5 and inhibiting the phosphorylation of
PKR-like ER kinase (PERK), known to be both physically associated with GRP78, and by activating caspase-4.
Overall, the regulation of cellular GRP78 expression and location is suggested as a possible route through
which DHA can exert pro-apoptotic and antitumoral effects in colon cancer cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Glucose related protein of 78 kDa (GRP78) has been originally de-
scribed as a chaperon signaling protein located in the endoplasmic
reticulum (ER) and involved in the unfolded protein response (UPR)
[1,2], a reactive process induced in response to various stresses. It
was reported to exert an anti-apoptotic role either by binding to
and inactivating caspase-4 [3], or by binding and inhibiting the accu-
mulation of unfolded proteins in ER, and regulating ER Ca2+ storage
during ER stress [4].
The overexpression of GRP78 has been reported in several cancers
[5–9] and an aggressive phenotype and a poor prognosis were
observed in prostate cancer overexpressing this protein [10]. More-
over, GRP78 down-regulation was shown to suppress cancer growth
through inhibition of tumor cell proliferation and promotion of apo-
ptosis in a transgene-induced mammary tumor model [11].
A cell surface associated form of GRP78 was identiﬁed in some
tumors (prostate cancer, ovarian cancer and melanoma) [12], where).
l rights reserved.it acted as a signaling receptor that promotes proliferation and sur-
vival [12]. By ﬁngerprinting the circulating repertoire of antibodies
from cancer patients Arap et al. [13] identiﬁed GRP78 as a relevant
molecular target expressed in metastatic tumors, and observed that
GRP78 binding peptide motifs speciﬁcally targeted tumor cells in vivo
and human cancer specimen ex vivo. The presence of autoantibodies
against a speciﬁc GRP78 α2-macroglobulin (α2-M) binding site was
reported in the serum of patients with prostate, ovary and skin cancer,
and it was associated to a poor prognosis [13,14]. Conversely, the
binding of GRP78 to antibodies against its COOH-terminal domain was
reported to down-regulate proliferative signaling and stimulate apo-
ptosis [15].
We have been studying the antitumoral property of n−3 PUFAs
in colon cancer for many years [16–19]. In particular, we and many
other authors have reported the pro-apoptotic activity exerted by
the long-chain n−3 PUFA docosahexaenoic acid (DHA) in colon and
other kinds of cancer cells [20–22]. Several mechanisms have been
invoked to explain the effects of DHA, including the DHA-induced
alteration in the expression and/or activity of cell surface components
involved in cell proliferation and survival pathways. It has been
suggested that the high level of unsaturation and extreme ﬂexibility
of DHA may lead to a high level of molecular disorder in the
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their physical–chemical properties and in the activity and expression
of proteins residing there [23].
The surface expression of GRP78 in some tumors and its ability
to regulate cancer cell proliferation and survival suggested us that
GRP78 placed on the surface of cancer cells could represent a target
of DHA proapoptotic action. Recently, Lee et al. [24] observed a mod-
ulation of the total expression of GRP78 by DHA in hepatocarcinoma
cells and suspected that this protein could play a role in the effects
of DHA on cell death in those cells. On these bases, we have investi-
gated whether this protein could exhibit a cell surface expression
pattern in colon cancer cell lines, and how the growth and survival
of these cells could be affected by the modulation of GRP78 total
and surface expression. Hence, we have studied the effect of DHA
on GRP78 expression and its possible involvement in the pro-
apoptotic effect of this fatty acid.
2. Materials and methods
2.1. Cell lines and treatments
Human colon adenocarcinoma cell lines HT-29, HCT116 and
SW480 were purchased from ATCC (American Type Culture Collec-
tion, Manassas, VA, USA). HT-29 and HCT116 cells were grown in
RPMI 1640 and DMEM medium, respectively, containing glutamine
(2 mM) and antibiotics (penicillin 10 U/ml, streptomycin 10 μg/ml);
SW480 cells were grown in DMEM medium containing glutamine
(2 mM) without antibiotics. All cell lines were supplemented with
10% fetal bovine serum and maintained in a humidiﬁed atmosphere
at 37 °C in the presence of 5% CO2. Cells were maintained in the log
phase by seeding twice a week at a density of 3×105 cells/ml.
DHA, eicosapentaenoic acid (EPA, 20:5 n−3), linoleic acid (LA, 18:2
n−6) and oleic acid (OA, 18:1 n−9) were purchased from Sigma-
Aldrich (Sigma, St. Louis, MO, USA). The fatty acids were added from
an absolute ethanol stock solution, and the control cells were treated
with the same amount of vehicle alone. The ﬁnal ethanol concentration
never exceeded 0.5% (v/v).
The speciﬁc ERK inhibitor PD98059was purchased fromCalbiochem
(Darmstadt, Germany), and thapsigargin and 2-deoxyglucose were
obtained from Sigma-Aldrich (Sigma, St. Louis, MO, USA).
2.2. Apoptosis detection
Apoptosis was measured by acridine orange-ethidium bromide
method [25] and analyzed by ﬂuorescence microscopy. Apoptosis
was also assessed using M30-cytodeath monoclonal primary anti-
body, which is directed against a speciﬁc epitope of cytokeratin 18
(CK18) that is formed by early caspase cleavage in the apoptotic cells
[26]. Cells were plated in four-well chamber slides (Nunc, Rochester,
NY, USA), ﬁxed with ice-cold pure methanol at −20 °C for 30 min,
washed twice in 0.01 M phosphate-buffered saline (PBS) pH 7.4 and
incubated with primary mouse monoclonal M30-cytodeath antibody
(Alexis Biochem., San Diego, CA, USA) diluted 1:100 in PBS containing
1% bovine serum albumin (BSA) for 60 min at room temperature
(RT). After two washings in PBS for 10 min, the anti-mouse IgG Cy2
conjugated antibody (Jackson Immunosearch Lab., West Grove, PA,
USA) diluted 1:200 in PBS was added for 60 min at RT. Cells were
then washed in PBS and mounted in Vectashield with a DAPI mounting
medium (Vector, Burlingame, CA, USA). Cells were observed using a
Zeiss Axiophot (Germany) ﬂuorescence microscope (20×). For quanti-
tative analysis, M30-positive cells that fell into six randomly selected
50 μm squares for each slide were counted using a computerized sys-
tem. The percentage of immunoreactivity of positive vs. total number
of counted cells in each ﬁeld was determined. For this purpose, images
from immunostained sections were captured using a Zeiss AxioCam
MRc camera (Zeiss, Germany) coupled to a Windows XP professionalcomputer (Microsoft). The number of cells was then evaluated on the
captured images using the Axiovision Release 4.4 software (Carl Zeiss
Vision).
2.3. Western blot analysis
Cell extracts were prepared by lysing the cells (1×107) in ice-cold
lysis buffer (1 mM MgCl2, 350 mM NaCl, 20 mM Hepes, 0.5 mM
EDTA, 0.1 mM EGTA, 1 mM Na4P2O4, 1 mM PMSF, 1 mM aprotinin,
1.5 mM leupeptin, 20% glycerol, 1% NP-40), as previously described
[27]. The protein content was determined by Bradford method using
the Biorad assay (Hercules, CA, USA) [28]. Equal amounts of proteins
(50 μg) were separated on a 10% sodium dodecyl sulfate polyacryl-
amide gel and electroblotted on a nitrocellulose membrane. The
membrane was blocked overnight at 4 °C in 5% dried milk (w/v) in
PBS plus 0.05% Tween 20 and then incubated with speciﬁc antibodies
to GRP78 (clone H-129, catalog # sc-13968, Santa Cruz Biotechnology,
Santa Cruz, CA), ERdj5 (clone 66.7, catalog # sc-100713, Santa Cruz
Biotechnology), ERK1/2 (clone K23, catalog # sc-94), p-ERK (clone
E-4, catalog # sc-7383), p-PERK (clone Thr 981, catalog # sc-32577,
Santa Cruz Biotechnology), PERK (clone H-300, catalog # sc-13073,
Santa Cruz Biotechnology), caspase 7 (catalog # 9492, Cell Signaling,
Beverly, MA), and GFP (clone B-2, catalog # sc-9996, Santa Cruz
Biotechnology).
As loading controls, the blots were reprobed with an anti-α-
actinin antibody (clone B-12, catalog # sc-166524, Santa Cruz Labora-
tories) at a 1:1000 dilution. Following incubation with secondary
mouse (ERdj5, p-ERK, GFP) or rabbit (GRP78, caspase-7, ERK1/2,
p-PERK, PERK) antibodies (Amersham, Pharmacia Biotech Italia,
Milan, Italy), the immunocomplexes were visualized using the en-
hanced chemiluminescence detection system (Amersham) and quan-
titated by densitometric scanning.
2.4. Immunoprecipitation
Cells were detached from the culture plates by gentle scraping in
ice-cold PBS and centrifuged at 2000 rpm for 5 min at 4 °C. Ice-cold
lysis buffer containing protease inhibitors was added to the cell pellet.
Samples were incubated at 4 °C for 30 min on a rotating platform and
then centrifuged at 14,000 rpm for 10 min in a refrigerated centri-
fuge. Supernatants were collected and pellets were discarded. 1 mg
of total proteins for each sample was incubated overnight in the pres-
ence of anti-PERK antibody or in the presence of normal rabbit IgG
(2 μg/ml). Then, 30 μl of A/G plus Agarose (Santa-Cruz Biotechnology)
was added and the samples were incubated for 2 h at 4 °C on a rotating
platform. The sampleswere then centrifuged (14,000 rpm for 5 min) to
collect the beads and then threewasheswith 500 μl ice-cold lysis buffer
were performed. 30 μl of lysis buffer and 10 μl of 6× Laemmli sample
buffer were added to the beads, samples were boiled for 5 min and
then western blot analysis of ERdj5, GRP78 and p-PERKwas performed.
2.5. Plasmids and transfection
The ER-GFP and GRP78-GFP constructs were a generous gift from
Erik Lee Snapp at the Albert Einstein College of Medicine, Bronx,
New York and have been previously described [29]. For all the
overexpression experiments, constructs were transiently transfected
for 48–72 h into cells using Effectene Transfection Reagent (Qiagen,
Hilden, Germany) according to the manufacturer's instructions.
2.6. Confocal microscopy
Cells were plated in eight-well chamber slides (104 cells/well) and
after 24 h (time necessary to allow cell adhesion) cells were treated
or not with 30 μM DHA for 6 h. Then, cells were ﬁxed with ice-cold
pure methanol at −20 °C for 30 min, washed twice in 0.01 M
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rabbit polyclonal GRP78 antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) diluted 1:200 in PBS containing 3% BSA for 60 min at
room temperature (RT). After two washings in PBS for 10 min the
anti-rabbit IgG Cy2 conjugated antibody (Jackson Immunosearch
Lab., West Grove, PA, USA) diluted 1:200 in PBS was added for
60 min at RT. Cells were then washed in PBS and mounted in
a Vectashield mounting medium (Vector, Burlingame, CA, USA).
Cells were observed and images were captured with 63× objectives
using a confocal microscope system (LSM 510 META; Carl Zeiss
MicroImaging, Thornwood, NY). The Axiovision Zeiss v. 4.8.0. software
was used for quantitative analysis; the intensity of immunoﬂuorescence
was evaluated by considering the mean of the values of ﬂuorescence in
10 randomly selected squares for each sample.
2.7. mRNA extraction and analysis
Total RNA was extracted from cells using Trizol according to
manufacturer's protocols (Invitrogen Life Technologies, Paisley, UK).
The RNA was eluted in diethylpyrocarbonate (DEPC)-treated water
(0.01% DEPC) and stored at −80 °C until reverse transcriptase poly-
merase chain reaction (RT-PCR) analysis. Nucleic acid concentrations
were measured by spectrophotometry (Hewlett-Packard HP UV/VIS
spectrophotometer 8450). RT-PCR assay was performed using the
two-step method. For the ﬁrst-step of reverse transcription, we used
QuantiTect reverse transcription kit (Qiagen, Hilden, Germany) with
500 ng of total RNA as template RNA, following themanufacturer's pro-
cedure. For the second step of PCR reactions we employed QuantiTect
SYBR® Green Kits (Qiagen) and QuantiTect® Primer Assays (Qiagen)
for human GRP78 (HSPA5-QT00096404) and β-actin (QT01680476),
according to manufacturer's protocol described for the real-time
thermalcycler LightCycler (Roche, Mannheim, Germany). In detail, the
conditions for PCR were as follows: 95 °C for 15 min (1 cycle of initial
activation), 94 °C for 15 s (denaturation), 55 °C for 20 s (annealing),
and 72 °C for 20 s (extension). Ampliﬁcation was carried out for
40 cycles. Melting curve analysis was based on the transition from
60 °C to 95 °C,with a temperature ramping of 0.05 °C/s, and continuous
detection of amplicon ﬂuorescence.
PCR data obtained by the LightCycler software were automatically
analyzed by the Relative Quantiﬁcation Software (Roche) and
expressed as target/reference ratio. Our approach was based on the
calibrator-normalized relative quantiﬁcation including correction for
PCR efﬁciency.
2.8. Caspase-4 activity
The activity of caspase-4 was assessed using a commercial colori-
metric assay (BioVision Research Products, Mountain View, CA, USA)
following the manufacturer's instructions. Brieﬂy, cells (5×106) were
pelleted, resuspended in 50 μl of chilled Cell Lysis Buffer and incubated
on ice for 10 min. The samples were then centrifuged at 10,000×g for
1 min, and the supernatant (cytosolic extract) was transferred in a
fresh tube and put on ice. The protein concentration of the cytosolic
extract was evaluated and 300 μg of proteins for each samplewas dilut-
ed in 50 μl of cell lysis buffer. 50 μl of 2× reaction buffer (containing
10 mM DTT) and 5 μl of LEVD-pNA substrate (200 μM ﬁnal concentra-
tion) were added to each sample. After incubation for 2 h at 37 °C, the
samples were read at 405 nm in a microtiter plate reader.
2.9. Statistical analysis
The results were expressed as the means±SEM. Two-way analy-
sis of variance (ANOVA) was used to assess signiﬁcant differences
in Figs. 1 and 2D. One-way analysis of variance (ANOVA) was used
to determine signiﬁcant differences among groups in Figs. 2E, 3, 5, 6
and 7 and Supplementary Figs. 2 and 3. When signiﬁcant valueswere found (pb0.05), post hoc comparisons of means were made
using Tukey's honestly signiﬁcant differences test. Unpaired t-test
was used to assess differences among groups in Figs. 4 and 7A and
Supplementary Fig. 1.
3. Results
Fig. 1A shows the concentration-dependent pro-apoptotic effect of
DHA in three different colon cancer cell lines (HT-29, HCT116 and
SW480 cells). The effect was evaluated after 48 h of treatment with
DHA by examining the morphologic features of apoptosis in cells
stained with acridine-orange. The cells were equally sensitive to
DHA, and a 7 fold increase in the pool of apoptotic cells was noticed
with the maximal concentration of DHA used (30 μM). However, a
much larger fraction of SW480 cells (about 60% with 30 μM DHA)
underwent DHA-induced apoptosis than the HCT116 or HT-29 cells
(about 15–18% with 30 μM DHA), and that was related to the greater
basal propensity for apoptosis of the SW480 cells (percentage of apo-
ptotic cells in basal conditions: 10.3±2, 2.1±0.3, 3.2±0.6, in SW480,
HT-29 and HCT116 cell lines, respectively).
The induction of apoptosis by DHA was conﬁrmed also by staining
SW480 cells with the anti-M30 antibody, a speciﬁc tool to investigate
early apoptotic stages, as it is directed against the caspase-cleaved
cytokeratin 18 formed during early apoptosis in epithelial cells [26]
(Fig. 1B–E).
A similar pro-apoptotic effect, even though smaller, was also
noticed when the cells were incubated with the other long chain
n−3 PUFA EPA (20:5 n−3), whereas no effect was exhibited when
the cells were exposed to LA (18:2 n:6) or OA (18:1 n:9), thus dem-
onstrating the speciﬁcity of the pro-apoptotic effect for n−3 PUFAs,
and, especially for DHA (Fig. 1F).
We observed that SW480 cells, besides having a high basal
attitude to undergo apoptosis, showed also lower levels of GRP78 ex-
pression than both HT-29 and HCT116 cells (Fig. 2A). Since the
anti-apoptotic role exerted by this protein has been described, this
ﬁnding prompted us to consider the possible involvement of GRP78
expression in the pro-apoptotic effect of DHA. We found that DHA
was able to further decrease the already low level of GRP78 expres-
sion of SW480 cells, and made it in a concentration-dependent man-
ner (Fig. 2B), thus leaving the cells practically devoid of GRP78 when
added at the maximal concentration (30 μM). When we induced the
overexpression of this protein in SW480 cells by transfecting them
with GRP78-GFP cDNA (Fig. 2C) a signiﬁcant induction of cell growth
(Fig. 2D), as well as a decreased basal capacity to undergo apoptosis
(Fig. 2E) was observed. Moreover, we noticed (Fig. 2E) that, after
GRP78-GFP transfection, the SW480 cells became unable to respond
to the pro-apoptotic stimulus of DHA, thus conﬁrming the involve-
ment of GRP78 in the induction of apoptosis brought about by DHA
in colon cancer cells. We also observed that in HCT116 and HT-29
cells, showing a high basal level of GRP78, the same concentration
of DHA able to induce apoptosis also decreased the expression of
GRP78 protein (35% and 73% decrease in HCT116 and HT-29 cells,
respectively) (Fig. 3A–C). However, the maximal GRP78 decrease
was observed as early as after 2 h in HT-29 cells, whereas 6 h was
needed to observe the same effect in HCT116 cells. In SW480, show-
ing a low basal level of GRP78, DHA caused a GRP78 reduction of
75%. Correspondingly, in HT-29 and in HCT116 cells we observed
(Supplementary Fig. 1) that DHA also induced a decrease in GRP78
mRNA, that was observed as early as after half an hour in HT-29
cells and after 2 h in HCT116 cells, suggesting that a decreased tran-
scription of GRP78 was involved in the pro-apoptotic effect of DHA.
However, the signiﬁcant but slight decrease in GRP78 mRNA expres-
sion induced by DHA (about 26% in both HCT116 and HT-29 cells)
cannot completely justify the higher decrease that DHA caused in
GRP78 protein (35% and 73% in HCT116 and HT-29), suggesting that
DHA may reduce GRP78 protein expression by acting not exclusively
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Fig. 1. Pro-apoptotic effect of DHA in colon cancer cell lines. (A): HT-29, HCT116 and SW480 colon cancer cells were exposed to DHA (10–30 μM) for 48 h, and apoptosis was mor-
phologically evaluated after acridine-orange staining. (B–E): Representative images of ﬂuorescence microscopy analysis of HCT116 cells treated for 48 h with 30 μM DHA, and
stained with the M30 cytodeath antibody (B and D) or counterstained with DAPI (C and E). (F): HT-29, HCT116 and SW480 colon cancer cells were exposed to 30 μM DHA,
EPA, LA or OA for 48 h and apoptosis was morphologically evaluated after acridine-orange staining. (A and F): The data are the means±SEM of four different experiments.
(A) The cell type/concentration interaction is signiﬁcant (pb0.0001, two-way ANOVA); (F) the cell type/treatment interaction is signiﬁcant (pb0.0001, two-way ANOVA). Values
not sharing the same superscript are signiﬁcantly different.
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thapsigargin (TG), an inducer of ER-stress able to up-regulate
GRP78 in many different kinds of cells [6,15,30,31] (Fig. 3A–D). In
all the cell lines the expression of GRP78 was markedly induced by
TG, and the concomitant treatment with DHA was able to substantial-
ly decrease (Fig. 3A–C) the expression of GRP78 (30 μM DHA: 94%,
51% and 56% in HT-29, HCT116 and SW480 cells, respectively). We
analyzed (Supplementary Fig. 2) also the effect of TG on apoptosis
in HCT116 cells, and found that TG at the concentration used to in-
duce GRP78 expression (Supplementary Fig. 2A) was able to slightly
induce apoptosis (2 fold increase), but at lower levels than DHA
(about 7 fold increase, see Fig. 1). The treatment of the same cells
with 2-deoxyglucose (2-DG), another potent ER stress inducer, did
not induce apoptosis in these cells (Supplementary Fig. 2A), when
used at the concentration able to maximally enhance GRP78 expres-
sion (Supplementary Fig. 2B), in agreement to what was previously
observed by Zhang et al. in HT-29 cells [32]. These results demon-
strate that the induction of ER stress per se (and the related GRP78
overexpression) is not always associated to apoptosis in colon cancer
cells. Moreover, if apoptosis is observed in these conditions, it never
reaches the levels obtained with DHA.
We next performed the immunoﬂuorescent staining of GRP78
in HCT116 cells in order to investigate by confocal microscopy the cel-
lular distribution of this protein. We chose HCT116 cells for their high
basal expression of GRP78, that allowed a better deﬁnition of the
cellular positions occupied by this protein. We observed that GRP78
had a ubiquitous distribution in HCT116 cells in basal conditions,even though a particularly intense staining was present at the cell
surface (Fig. 4A). DHA treatment dislocated the GRP78 protein from
the surface location (Fig. 4B) inducing a 49.5±3.1% decrease of
GRP78 expression at the cell surface, and making the cell boundaries
extremely ill-deﬁned. Instead, the distribution of GRP78 in other cel-
lular districts (cytoplasm and nuclei) did not change in the presence
of DHA.
We observed that a considerable fraction of the GRP78 over-
expressed in HCT116 cells after transfection with GRP78-GFP was
also associated with the cell plasma membrane (Fig. 4A and C, plain
arrows). These ﬁndings conﬁrm the speciﬁc, even though not exclu-
sive, plasma membrane location of GRP78 in colon cancer cells, both
in basal conditions and after induction of its expression (by transfec-
tion). Actually, in the last case the nuclear membrane also became
stained by GRP78-GFP ﬂuorescence (Fig. 4C and D, dashed arrow)
and no ﬂuorescence was detected in the nuclei, suggesting that the
artiﬁcial condition of GRP78-GFP transfection may lead to a different
spatial organization of GRP78, excluding the nuclei. DHA induced in
both cases the decrease of GRP78 from the surface position (49.2±
3.2%, DHA-induced GRP78 decrease in wild type HCT116 cells; 35.0±
2.1% DHA-induced GRP78‐GFP decrease in HCT116 transfected cells)
(Fig. 4E and F), as measured by confocal microscope quantitative
analysis.
Since it was demonstrated in melanoma cells that GRP78may repre-
sent a target of the MEK/ERK pathway [3], and we had previously ob-
served [17] that DHA reduced ERK1/2 phosphorylation in colon cancer
cells, we have considered thepossibility that theDHA-induced reduction
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the alteration of pERK1/2 produced by DHA in colon cancer cells. We
conﬁrmed in HCT116 cells that after DHA treatment the expression of
pERK1/2 was reduced (Fig. 5A), and the reduction was noticed as early
as after 1 h, before GRP78 started to decrease (at 6 h, Fig. 3C, D). To sup-
port the hypothesis that the inhibition of ERK could be involved in
DHA-induced GRP78 down-regulation and apoptosis in colon cancer
cells, we treatedHCT116 cellswith 20 μMPD98059, a speciﬁc ERK inhib-
itor. Similar to what was observed with DHA, the effect produced by
this compound was to reduce the expression of pERK1/2 earlier (after
30 min) than that of GRP78 (after 2 h), and ﬁnally to induce apoptosis
(Fig. 5B, C), suggesting that the ERK/GRP78 pathway may play a crucial
role in the apoptosis-inducing effect of DHA observed in colon cancer
cells.
The addition of DHA to the cells also caused an increase in the
expression of ERdj5, another component of the signaling pathway of
ER stress localized in the ER. We observed that, concomitant to the
decrease of GRP78, DHA also induced an increase of ERdj5 (Fig. 6A).
This protein was observed to sensitize neuroblastoma cells to ER
stress-induced apoptosis by inactivating PERK, a factor involved in
the ER stress-induced UPR, thus down-regulating this survival path-
way [33]. ERdj5 has been suggested to exert this effect either by a
direct interaction with PERK or through the interaction with GRP78which can form a complex with PERK [33]. We found that both
GRP78 and ERdj5 co-immunoprecipitated with PERK in colon cancer
cells (Fig. 6B) and that DHA treatment reduced the binding between
GRP78 and PERK, whereas it did not modify the binding between
PERK and ERdj5. Moreover, we observed that the treatment with
DHA was able to decrease the phosphorylation of PERK, both in
basal conditions and after its induction by TG (Fig. 6C). These ﬁndings
suggest that the altered binding between GRP78 and PERK may be
related to the reduction of PERK phosphorylation induced by DHA,
and in turn contribute to the DHA-induced apoptosis.
The anti-apoptotic role of GRP78 has been previously related to its
capacity to inhibit the activation of caspase-4 [3,34], which plays a
role in the induction of apoptosis by ER stress and also contributes
to TRAIL-induced apoptosis [3,34–36]. In agreement, we found that
the treatment of colon cancer cells with DHA, while reducing the
expression of GRP78 protein and mRNA, also induces the cleavage
and activation of caspase-4 (Fig. 7A). As a matter of fact, in SW480
cells the activation of caspase-4 was inhibited by GRP78 transfection
by 31% (Fig. 7B).
DHA induced also the concentration-dependent cleavage of pro-
caspase-7 (Supplementary Fig. 3), which has been previously
reported to be inhibited by GRP78 through a speciﬁc physical asso-
ciation [37].
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In this study we demonstrated that the modulation exerted by
DHA on the expression and cellular location of the GRP78 protein
was involved in the pro-apoptotic effect of DHA in colon cancer
cells. We also suggested that pERK1/2, known to induce GRP78
expression, could be the ﬁrst upstream target for DHA. We also hy-
pothesized that, downstream of GRP78, DHA could act by reducing
pPERK expression and augmenting ERdj5 expression and caspase-4
and ‐7 activation.
We conﬁrmed here the pro-apoptotic effect of DHA previously
reported by us [17,18] and others [38–41] in colon cancer cell lines,
and demonstrated that this effect was speciﬁc for n−3 PUFAs (DHA
and EPA) and not observed with other types of fatty acids (the n−6
PUFA LA and the monounsaturated fatty acid OA). Moreover, we
found that, as an apoptotic inducer, DHA was more efﬁcient than
EPA, which, used at the same concentrations of DHA, either induced
apoptosis (in HCT116 and SW480 cells) with lower efﬁciency than
DHA or did not induce apoptosis (in HT-29 cells) at all. We observed
that the percentage of cells driven by DHA towards apoptosis largely
differed among the three different cell lines, being about 3–4 folds
higher among SW480 cells than among HT-29 and HCT116 cells.
The efﬁciency with which DHA induced apoptosis, however, wasnot dissimilar among the three different cell lines, since, irrespective
of the cell line, 30 μM DHA always induced approximately a 7 fold
increase in the percentage of apoptotic cells. However, the basal atti-
tude to undergo apoptosis was much higher in SW480 cells than in
HCT116 and HT-29 cells, as demonstrated by the signiﬁcantly larger
basal pool of apoptotic cells within the SW480 cell population than
within the two others. We correlated the high basal attitude of
SW480 cells to undergo apoptosis, as well as the larger SW480 popu-
lation of cells undergoing apoptosis following DHA treatment, to the
signiﬁcantly lower levels of GRP78 protein expression of these cells,
because several authors had previously established an anti-apoptotic
role for this protein in several kinds of cancer cells [42,43]. These
authors had also showed that, different from normal cells, GRP78 is
overexpressed in a series of cancer cells where it is associated to an
aggressive phenotype and a poor prognosis [42,43]. The variable degree
of GRP78 expression that we observed in the colon cancer cell lines was
also in keepingwithwhatwas previously reported by Ramsay et al. [44]
in other colon cancer cell lines.
According to our hypothesis of an anti-apoptotic role for GRP78 in
colon cancer cells, the overexpression of this protein in SW480 cells,
obtained by transfecting them with GRP78-cDNA, signiﬁcantly
induced the growth of these cells (SW480GRP78 cells) and inhibited
their basal ability to undergo apoptosis. Moreover, we found that
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the already low basal GRP78 content of these cells in a concentration-
dependent manner, and this ﬁnding, together with the observed
concentration-dependent induction of apoptosis by DHA, further
corroborates the anti-apoptotic role of GRP78 in colon cancer cells. On
these bases, we hypothesized that the regulation of GRP78 expression
could be involved in the pro-apoptotic effect of DHA in colon cancer
cells. A support to this hypothesis came from the ﬁnding that
SW480GRP78 cells became insensitive to the pro-apoptotic effect of DHA.
The ability of DHA to reduce the expression of GRP78 in colon can-
cer cells was also demonstrated when this protein was markedly
overexpressed following the treatment of the cells with the ER stress
inducer TG. DHA added in combination with TG was able to revert the
increased total levels of GRP78 to those observed in basal conditions
(in HCT116 cells and SW480 cells) or even lower (in HT-29 cells).
When we compared the effect of TG on GRP78 expression with that
of 2-DG, another potent stress inducer, we found that, even though
both increased GRP78 expression, only TG was able to trigger apopto-
sis in colon cancer cells (and at a level much lower than DHA: 2-fold
induction against 7-fold induction). This ﬁnding strongly suggested
that the induced increase in GRP78 expression may not be involved
in the pro-apoptotic effect of TG in colon cancer cells, in agreement
to what was observed by He et al. [45]. These authors invoked a direct
engagement of the death receptor 5 by TG, with the consequent acti-
vation of caspase-8, as well as the TG-induced release of the DIABLOprotein from mitochondria, with the activation of caspase-9 to
explain the caspase-3 dependent apoptosis observed in TG-treated
colon cancer cells (with a 2-fold induction of caspase-3).
Beyond the well known location and function of GRP78 in the
ER, this protein has been recently found to be expressed also in
other cell compartments (cell surface, nuclei and mitochondria),
and its secretion has also been observed in endothelial cells [43].
Thus, it appears quite reductive considering GRP78 only as a chaperon
protein involved in the ER stress response. Whereas at the moment
the role of GRP78 in some cell compartments (i.e. the nucleus) is
not completely understood, at the surface of different cancer cells
[43,46–48], where it is expressed at high levels, it functions as a recep-
tor involved in the regulation of cancer cell growth and apoptosis [15].
Whereas the surface location was never observed in normal cells, in
some cancer cells (prostate cancer and melanoma cells) the increased
expression of GRP78 at the cell surface has been associated to a more
aggressive phenotype [49]. For these reasons we investigated the cel-
lular location of this protein in colon cancer cells (HCT116 cells), both
in basal conditions and after DHA stimulation. We observed that
GRP78 was localized in a substantial amount both at the cell surface
and in intracellular compartments in untreatedHCT116 cells, in agree-
ment with what was previously observed by Shin et al. [46] in LOVO
colon cancer cells. Since DHA reduced both the total level of GRP78,
as well as its surface expression in HCT116 cells, leaving, however,
substantially unaltered the expression of GRP78 residing in other
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total expression of GRP78 mainly by reducing its surface component.
This was conﬁrmed also by the disappearance of GRP78-GFP from
the surface position caused by DHA in HCT116 colon cancer cells
transfected with GRP78-cDNA.
In keeping with our ﬁndings, recently, Misra et al. [15] speciﬁcally
related the expression of GRP78 at the surface (GRP78surf) of pros-
tatic cancer cells to the anti-apoptotic role exerted by this protein
[15]. They observed that the binding of GRP78surf with antibodies
directed towards the COOH-terminal domain (anti-CDT Ab) of this
protein inhibited cell proliferation and promoted apoptosis in pros-
tate cancer cells. The anti-CDT Ab had a speciﬁcity different from
that of the auto-antibodies present in the serum of prostate cancer
patients, which are directed against the activated α2-macroglobulin
binding site in the NH2 terminal domain of GRP78, and that are
indicative of a poor prognosis [50]. The binding of anti-CTD Ab to
GRP78surf instead appeared to be protective, since it inhibited cancer
cell proliferation and promoted apoptosis [51]. These effects were re-
lated by the authors to the altered expression and activation of sever-
al factors that reside in ER such as PERK and ERdj5 [51], that are both
involved in the UPR signaling and exhibit the property of speciﬁcally
binding to GRP78, and being regulated by it. This implied that strictrelationships could exist between the regulation of GRP78surf and
the modulation of ER located GRP78-dependent proteins/activities.
In particular, these authors found that the expression of pPERK was
inhibited and that of ERdj5 was enhanced following the binding of
surface GRP78 to the anti-CTD Ab. The observation that DHA, besides
dislocating GRP78 from the colon cancer cell surface and inducing
apoptosis, also inhibited the expression of pPERK and enhanced that
of ERdj5, further strengthened the hypothesis that in colon cancer
cells DHA could induce apoptosis through a molecular pathway in-
volving GRP78, and in particular the pool of this protein located at
the cell surface. Moreover, it also suggested that this pathway could
involve an altered regulation of pPERK and ERdj5 expression. This
ﬁnding suggests that the DHA ability to decrease the expression of
surface GRP78 could induce effects comparable to those observed
when speciﬁc anti-CTD Ab binds and neutralizes GRP78 surface.
The induction of ERdj5 expression by DHA in colon cancer cells
could also help to explain the induction of apoptosis by this fatty
acid, since a pro-apoptotic role has been reported for ERdj5 [10]. Re-
cently, Thomas and Spyrou [33] observed that the overexpression of
ERdj5 sensitized neuroblastoma cells to ER stress-induced apoptosis
by inactivating PERK, thus abolishing the induction of UPR signaling.
These authors hypothesized that one possibility for ERdj5 to inacti-
vate PERK could be its direct interaction with GRP78, and, through
this route, the modulation of the GRP78–PERK complex and PERK
activity. Since we found that GRP78 and ERdj5 were physically associ-
ated and both co-immunoprecipitated with PERK, and, in agreement
with the hypothesis of Thomas and Spyrou [33], we hypothesize that
the alterations induced by DHA on GRP78 and ERdj5 expression
in colon cancer cells (the decrease for GRP78 and the increase for
ERdj5) could be closely related to each other. These ﬁndings suggest
that DHA, by decreasing the expression of GRP78 and increasing that
of ERdj5 may alter the interactions between GRP78 and ERdj5 and
between these two factors and PERK, thus leading to the inactivation
of PERK, and to the induction of ER stress-induced apoptosis. In agree-
ment, we found that caspase-4, which has been speciﬁcally involved
in ER stress-induced apoptosis, was activated by DHA in colon cancer
cells, and that its activation by DHAwas inhibited in colon cancer cells
overexpressing GRP78. These ﬁndings are in agreement with the acti-
vation of caspase-4 and the induction of apoptosis observed both in
malignant melanocytes whose GRP78 expression was silenced [3], and
in prostatic cancer cells treatedwith anti-CDT Ab to GRP78 [15].We ob-
served that the DHA treatment also induced pro-caspase-7 cleavage.
Since it was shown [37,52] that GRP78 may protect from ER
stress-induced apoptosis through the physical association and blocking
of pro-caspase-7 activation, a relationship between DHA-induced
GRP78 inhibition and caspase-7 activation can be suggested. How-
ever, we failed to observe a physical association between GRP78 and
pro-caspase-7 in colon cancer cells (data not shown). Nevertheless, it
should be noted that the reported pro-caspase-7/GRP78 association
[37,52] was observed with transfected GRP78, and the authors them-
selves [37] underlined that it was not known whether constitutive
GRP78 could form a complex with pro-caspase-7 under physiological
conditions. On the other hand, a number of reports have so far asso-
ciated the inhibition of GRP78 by antineoplastic agents with caspase-7
activation [53,54].
It was previously demonstrated that the inhibition of the MEK/
ERK pathway sensitizes melanoma cells to ER stress-induced apopto-
sis [3] mediated by caspase-4 activation and associated with inhibi-
tion of GRP78 expression, and that GRP78 may represent a target of
the MEK/ERK pathway [34]. In agreement, the observation that DHA
decreased the phosphorylation of ERK in colon cancer cells before
any visible inhibition of GRP78 expression prompted us to suggest
that DHA could reduce GRP78 expression by inhibiting the activation
of ERK also in colon cancer cells. Moreover, we suggested also that
this ERK/GRP78 pathway could play a crucial role in the apoptosis-
inducing effect of DHA in colon cancer cells, since their treatment
1771E. Fasano et al. / Biochimica et Biophysica Acta 1822 (2012) 1762–1772with the speciﬁc ERK inhibitor PD98059 decreased GRP78 expression
(by about 5 folds) and induced apoptosis (by about 4.5 folds), as also
observed after DHA treatment.
On the basis of the results obtained we can conclude that the
pro-apoptotic effect exerted by DHA in colon cancer cells may be re-
lated to the changes produced in the cellular expression and location
of GRP78. These alterations follow the modiﬁcations produced by
DHA in ERK1/2 phosphorylation, and are part of a signaling pathway
that couples changes in ERdj5 expression, PERK phosphorylation, and
caspase-4 and ‐7 activation to apoptosis induction.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbadis.2012.08.003.Acknowledgements
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